189 related articles for article (PubMed ID: 9293960)
21. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.
van der Horst IC; Zijlstra F; van 't Hof AW; Doggen CJ; de Boer MJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gans RO; Bilo HJ;
J Am Coll Cardiol; 2003 Sep; 42(5):784-91. PubMed ID: 12957421
[TBL] [Abstract][Full Text] [Related]
22. Myocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgery.
Shim JK; Yang SY; Yoo YC; Yoo KJ; Kwak YL
Br J Anaesth; 2013 Jan; 110(1):47-53. PubMed ID: 22986417
[TBL] [Abstract][Full Text] [Related]
23. Glucose, insulin and potassium for heart protection during cardiac surgery.
Bruemmer-Smith S; Avidan MS; Harris B; Sudan S; Sherwood R; Desai JB; Sutherland F; Ponte J
Br J Anaesth; 2002 Apr; 88(4):489-95. PubMed ID: 12066723
[TBL] [Abstract][Full Text] [Related]
24. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial.
Ceremuzyński L; Budaj A; Czepiel A; Burzykowski T; Achremczyk P; Smielak-Korombel W; Maciejewicz J; Dziubińska J; Nartowicz E; Kawka-Urbanek T; Piotrowski W; Hanzlik J; Cieśliński A; Kawecka-Jaszcz K; Gessek J; Wrabec K
Cardiovasc Drugs Ther; 1999 May; 13(3):191-200. PubMed ID: 10439881
[TBL] [Abstract][Full Text] [Related]
25. Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon.
Opie LH; Bruyneel K; Owen P
Circulation; 1975 Jul; 52(1):49-57. PubMed ID: 236843
[TBL] [Abstract][Full Text] [Related]
26. Glucose-insulin-potassium reduces infarct size when administered during reperfusion.
Jonassen AK; Aasum E; Riemersma RA; Mjøs OD; Larsen TS
Cardiovasc Drugs Ther; 2000 Dec; 14(6):615-23. PubMed ID: 11300362
[TBL] [Abstract][Full Text] [Related]
27. [Therapy with glucose-insulin-potassium reduces the complications in the acute phase of myocardial infarct. Arguments in favor].
Alegría Ezquerra E; Maceria González A
Rev Esp Cardiol; 1998 Sep; 51(9):720-6. PubMed ID: 9803797
[TBL] [Abstract][Full Text] [Related]
28. Therapy with insulin in cardiac surgery: controversies and possible solutions.
Doenst T; Bothe W; Beyersdorf F
Ann Thorac Surg; 2003 Feb; 75(2):S721-8. PubMed ID: 12607718
[TBL] [Abstract][Full Text] [Related]
29. Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia.
Di Marco S; Boldrini B; Conti U; Marcucci G; Morgantini C; Ferrannini E; Natali A
Clin Sci (Lond); 2010 Apr; 119(1):37-44. PubMed ID: 20001969
[TBL] [Abstract][Full Text] [Related]
30. Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services.
Selker HP; Beshansky JR; Griffith JL; D'Agostino RB; Massaro JM; Udelson JE; Rashba EJ; Ruthazer R; Sheehan PR; Desvigne-Nickens P; Rosenberg YD; Atkins JM; Sayah AJ; Aufderheide TP; Rackley CE; Opie LH; Lambrew CT; Cobb LA; Macleod BA; Ingwall JS; Zalenski RJ; Apstein CS
Am Heart J; 2012 Mar; 163(3):315-22. PubMed ID: 22424000
[TBL] [Abstract][Full Text] [Related]
31. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
[TBL] [Abstract][Full Text] [Related]
32. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations.
Lazar HL; Chipkin S; Philippides G; Bao Y; Apstein C
Ann Thorac Surg; 2000 Jul; 70(1):145-50. PubMed ID: 10921699
[TBL] [Abstract][Full Text] [Related]
33. Glucosa-Insulin-Potassium (GIK) solution used with diabetic patients provides better recovery after coronary bypass operations.
Straus S; Gerc V; Kacila M; Faruk C
Med Arch; 2013; 67(2):84-7. PubMed ID: 24341049
[TBL] [Abstract][Full Text] [Related]
34. [Attenuation of irreversible rat heart injury by reperfusion with metabolic protectors].
Pisarenko OI; Serebriakova LI; Tsikitishvili OV; Studneva IM
Biomed Khim; 2008; 54(6):659-70. PubMed ID: 19205425
[TBL] [Abstract][Full Text] [Related]
35. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials.
Schipke JD; Friebe R; Gams E
Eur J Cardiothorac Surg; 2006 Apr; 29(4):479-85. PubMed ID: 16481185
[TBL] [Abstract][Full Text] [Related]
36. Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.
Türel B; Gemici K; Baran I; Yeşilbursa D; Güllülü S; Aydinlar A; Serdar A; Kazazoğlu AR; Kumbay E; Cordan J
Anadolu Kardiyol Derg; 2005 Jun; 5(2):90-4. PubMed ID: 15939681
[TBL] [Abstract][Full Text] [Related]
37. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs.
Zhang HX; Zang YM; Huo JH; Liang SJ; Zhang HF; Wang YM; Fan Q; Guo WY; Wang HC; Gao F
J Cardiovasc Pharmacol; 2006 Dec; 48(6):306-13. PubMed ID: 17204910
[TBL] [Abstract][Full Text] [Related]
38. [Effects of cardioplegic solutions on coronary artery and myocardium--comparison of the glucose-insulin-potassium solution and the St. Thomas' Hospital cardioplegic solution].
Watanabe H; Yokosawa T; Eguchi S; Imai S
Nihon Kyobu Geka Gakkai Zasshi; 1989 Oct; 37(10):2142-9. PubMed ID: 2685132
[TBL] [Abstract][Full Text] [Related]
39. Role of metabolically active drugs in the management of ischemic heart disease.
Schofield RS; Hill JA
Am J Cardiovasc Drugs; 2001; 1(1):23-35. PubMed ID: 14728049
[TBL] [Abstract][Full Text] [Related]
40. Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization.
Yazici M; Demircan S; Durna K; Yasar E; Acar Z; Sahin M
Am J Cardiol; 2005 Dec; 96(11):1517-20. PubMed ID: 16310433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
